Evaluation of FGF 23 (c-terminal and intact) ELISA kits in end-stage renal disease patients

被引：0
|
作者：
Fassbender, W. J. [1 ]
Hanfland-Schtnidt, M. [1 ]
Windolf, J. [2 ]
Stumpi, U. C. [2 ]
机构：
[1] Hosp HI Geist, Dept Internal Med, Kempen, Germany
[2] Univ Hosp, Dept Traumatol & Handsurg, Dusseldorf, Germany
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
M211
引用
收藏
页码：S173 / S173
页数：1
相关论文
共 50 条
  • [1] Evaluation of Human Fibroblast Growth Factor 23 (FGF-23) C-Terminal and Intact Enzyme-Linked ImmunoSorbent-Assays in End-Stage Renal Disease Patients
    Fassbender, W. J.
    Brandenburg, V
    Schmitz, S.
    Sandig, D.
    Simon, S. A.
    Windolf, J.
    Stumpf, U. C.
    CLINICAL LABORATORY, 2009, 55 (3-4) : 144 - 152
  • [2] FGF-23 in patients with end-stage renal disease on hemodialysis
    Imanishi, Y
    Inaba, M
    Nakatsuka, K
    Nagasue, K
    Okuno, S
    Yoshihara, A
    Miura, M
    Miyauchi, A
    Kobayashi, K
    Miki, T
    Shoji, T
    Ishimura, E
    Nishizawa, Y
    KIDNEY INTERNATIONAL, 2004, 65 (05) : 1943 - 1946
  • [3] FGF-23 in patients with end-stage renal disease on hemodialysis
    Imanishi, Y
    Nakatsuka, K
    Inaba, M
    Nagasue, K
    Okuno, S
    Miura, M
    Miyauchi, A
    Kobayashi, K
    Ishimura, E
    Nishizawa, Y
    BONE, 2003, 32 (05) : S116 - S116
  • [4] Side Selective Renal Reduction of Intact and C-Terminal FGF-23
    Sharma, Shilpa
    Houben, Alfons J.
    Kroon, Abraham A.
    de Leeuw, Peter W.
    Hoofnagle, Andrew N.
    Katz, Ronit
    Bullen, Alexander
    Ginsberg, Charles
    Ix, Joachim H.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 211 - 212
  • [5] Skeletal manifestations in end-stage renal disease patients and relation to FGF23 and Klotho
    Magdalena, Tomsa Anamaria
    Leonard, Alexa Alexandru
    Liana, Rachisan Andreea
    Andrei, Picos
    Monica, Picos Alina
    Lorena, Ciumarnean
    BALNEO RESEARCH JOURNAL, 2020, 11 (03) : 274 - 278
  • [6] The effect of burosumab on intact and C-terminal FGF23 measurements
    Ashrafzadeh-Kian, Susan Louise
    Ito, Nobuaki
    Srivastava, Tarak
    Garg, Uttam
    Kato, Hajime
    Algeciras-Schimnich, Alicia
    Bornhorst, Joshua A.
    CLINICAL ENDOCRINOLOGY, 2023, 99 (02) : 152 - 157
  • [7] Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
    Smith, Edward R.
    Cai, Michael M.
    McMahon, Lawrence P.
    Holt, Stephen G.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (09): : 3357 - 3365
  • [8] Cystatin C and Seminal Parameter Evaluation in Patients with End-Stage Renal Disease
    不详
    CURRENT UROLOGY, 2021, 15 (04)
  • [9] Associations of Intact and C-Terminal FGF23 with Inflammatory Markers in Older Patients Affected by Advanced Chronic Kidney Disease
    Abinti, Matteo
    Vettoretti, Simone
    Caldiroli, Lara
    Mattinzoli, Deborah
    Ikehata, Masami
    Armelloni, Silvia
    Molinari, Paolo
    Alfieri, Carlo Maria
    Castellano, Giuseppe
    Messa, Piergiorgio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (13)
  • [10] Evaluation of proBNP in End-stage Renal Disease Patients on Hemodialysis
    Nakagawa, Yasuaki
    Nishikimi, Toshio
    Kuwahara, Koichiro
    Yasuno, Shinji
    Kinoshita, Hideyuki
    Kuwabara, Yoshihiro
    Nakao, Kazuhiro
    Yamada, Chinatsu
    Ueshima, Kenji
    Nakao, Kazuwa
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (10) : S168 - S168
12345